BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eldahshan W, Ishrat T, Pillai B, Sayed MA, Alwhaibi A, Fouda AY, Ergul A, Fagan SC. Angiotensin II type 2 receptor stimulation with compound 21 improves neurological function after stroke in female rats: a pilot study. Am J Physiol Heart Circ Physiol 2019;316:H1192-201. [PMID: 30822121 DOI: 10.1152/ajpheart.00446.2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Lansdell TA, Chambers LC, Dorrance AM. Endothelial Cells and the Cerebral Circulation. Compr Physiol 2022;12:3449-508. [PMID: 35766836 DOI: 10.1002/cphy.c210015] [Reference Citation Analysis]
2 Fouda AY, Ahmed H, Pillai B, Kozak A, Hardigan T, Ergul A, Fagan SC, Ishrat T. Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke. Neurochemistry International 2022. [DOI: 10.1016/j.neuint.2022.105375] [Reference Citation Analysis]
3 Fouda AY, Eldahshan W, Xu Z, Lemtalsi T, Shosha E, Zaidi SA, Abdelrahman AA, Cheng PN, Narayanan SP, Caldwell RW, Caldwell RB. Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury. Exp Neurol 2021;348:113923. [PMID: 34780773 DOI: 10.1016/j.expneurol.2021.113923] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
4 Fussi MF, Hidalgo F, Buono GM, Marquez SB, Pariani AP, Molinas JL, Larocca MC, Monasterolo LA, Molinas SM. Angiotensin II type 2 receptor agonist, compound 21, prevents tubular epithelial cell damage caused by renal ischemia. Biochem Pharmacol 2021;194:114804. [PMID: 34678223 DOI: 10.1016/j.bcp.2021.114804] [Reference Citation Analysis]
5 Eldahshan W, Sayed MA, Awad ME, Ahmed HA, Gillis E, Althomali W, Pillai B, Alshammari A, Jackson L, Dong G, Sullivan JC, Cooley MA, Elsalanty M, Ergul A, Fagan SC. Stimulation of angiotensin II receptor 2 preserves cognitive function and is associated with an enhanced cerebral vascular density after stroke. Vascul Pharmacol 2021;141:106904. [PMID: 34481068 DOI: 10.1016/j.vph.2021.106904] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Jackson-Cowan L, Eldahshan W, Dumanli S, Dong G, Jamil S, Abdul Y, Althomali W, Baban B, Fagan SC, Ergul A. Delayed Administration of Angiotensin Receptor (AT2R) Agonist C21 Improves Survival and Preserves Sensorimotor Outcomes in Female Diabetic Rats Post-Stroke through Modulation of Microglial Activation. Int J Mol Sci 2021;22:1356. [PMID: 33572986 DOI: 10.3390/ijms22031356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
7 Steckelings UM, Sumners C. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci (Lond) 2020;134:2987-3006. [PMID: 33210709 DOI: 10.1042/CS20200922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
8 Sayed MA, Eldahshan W, Abdelbary M, Pillai B, Althomali W, Johnson MH, Arbab AS, Ergul A, Fagan SC. Stroke promotes the development of brain atrophy and delayed cell death in hypertensive rats. Sci Rep 2020;10:20233. [PMID: 33214598 DOI: 10.1038/s41598-020-75450-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
9 McFall A, Nicklin SA, Work LM. The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential. Cell Signal 2020;76:109809. [PMID: 33059037 DOI: 10.1016/j.cellsig.2020.109809] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Noureddine FY, Altara R, Fan F, Yabluchanskiy A, Booz GW, Zouein FA. Impact of the Renin-Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives. Int J Mol Sci 2020;21:E4268. [PMID: 32560034 DOI: 10.3390/ijms21124268] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Juillerat-Jeanneret L. The Other Angiotensin II Receptor: AT2R as a Therapeutic Target. J Med Chem 2020;63:1978-95. [PMID: 32030982 DOI: 10.1021/acs.jmedchem.9b01780] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
12 Wu Y, Lu X, Li M, Zeng J, Zeng J, Shen B, Zeng Y. Renin-angiotensin system in osteoarthritis: A new potential therapy. Int Immunopharmacol 2019;75:105796. [PMID: 31408841 DOI: 10.1016/j.intimp.2019.105796] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
13 Weeks KL, Henstridge DC, Salim A, Shaw JE, Marwick TH, McMullen JR. CORP: Practical tools for improving experimental design and reporting of laboratory studies of cardiovascular physiology and metabolism. Am J Physiol Heart Circ Physiol 2019;317:H627-39. [PMID: 31347916 DOI: 10.1152/ajpheart.00327.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]